導(dǎo)語：醫(yī)藥論文英文摘要中的常見錯(cuò)誤與評改一文來源于網(wǎng)友上傳，不代表本站觀點(diǎn)，若需要原創(chuàng)文章可咨詢客服老師，歡迎參考。

[關(guān)鍵詞]醫(yī)藥論文英文摘要

1、醫(yī)藥科技工作者撰寫醫(yī)藥論文時(shí)一般要求附英文摘要，英文摘要寫得準(zhǔn)確與否，很大程度上體現(xiàn)了作者的學(xué)術(shù)水平，也與論文的影響力有很大關(guān)系。我們有幸從《醫(yī)藥導(dǎo)報(bào)》雜志社獲取了相當(dāng)數(shù)量論文的英文摘要原稿。該刊特邀英文校譯——同華中科技大學(xué)同濟(jì)醫(yī)學(xué)院馮新為教授，年逾九旬仍伏案筆耕，為這些稿件做了大量細(xì)致深入的校譯工作，可謂句句汗水字字珠璣。給醫(yī)藥科技論文英文摘要的寫作提供了一個(gè)范本，對廣大醫(yī)藥科技工作者來說也是一次極其珍貴的學(xué)習(xí)機(jī)會(huì)。本特輯錄刊載其原文及馮教授所作修正、點(diǎn)評，以饗讀者。

2、編制體例：本文按照原文、修正、點(diǎn)評次序編寫；修改、插入處以黑體斜體，刪節(jié)處附括號說明，如有點(diǎn)評附上標(biāo)數(shù)字注明。

1、原文：

DeterminationofGallicAcidinZhixuetingLiquidsbyTLCScanning

ZHOUQun1,XULa-ying2(1.DepartmentofPharmacology,TongjiMedicalC

ollege,HuazhongUniversityofScienceandTechnology,Wuhan430030,Ch

ina;2.TheFacultyofPharmacy,HubeiCollegeofTraditionalChineseMe

dicine,Wuhan430061,China)

ABSTRACTObjective:TodeterminethecontentofgallicacidinZhixueti

ngliquids.Methods:Zhixuetingliquidsweredissolvedbydistilledwat

er,andthenextractedintothesamplewithbutanaletc.Thesampleswe

redeterminatedbyTLCscanning(λS=280nm,λR=350nm).Result:Theaver

agerecoveryratewas96.36%andRSD=2.39%.Thecontentsofgallicacid

in3fivebatchesofsampleswere0.38,0.42and0.47mg/ml.Conclusion:

Themethodissimple,convenientandavailable.

KEYWORDSTLCScanning;Zhixuetingliquids;Determination;Gallicacid

修正：

DeterminationofGallicAcidinChuxueting1oralLiquidsbyTLCScannin

g

ZHOUQun1,XULa-ying2(1.SchoolofPharmacy2,TongjiMedicalCollege,

HuazhongUniversityofScienceandTechnology,Wuhan430030,China;2.

TheFacultyofPharmacy,HubeiCollegeofTraditionalChineseMedicine,

Wuhan430061,China)

AbstractObjective:TodeterminethecontentofgallicacidinChuxueti

ngoralLiquids.Methods:TheChuxuetingoralLiquidwasdissolvedind

istilledwater,andthenextracted（intothesample刪去）withwater-s

aturaledn-butanol3etc.forthepreparationofsamples.Thesampleswe

resubjectedtogallicaciddeterminationbyTLCscanning(λS=280nm,λ

R=350nm).Results:Theaveragerateofrecoverywas96.36%,（and刪去）

RSD=2.39%.Thecontentsofgallicacidin3（five刪去）batchesofsam

pleswere0.38,0.42and0.47mg/mlrespectively.Conclusion:Themethod

issimple,convenientandfeasible.

KEYWORDSTLCScanning;ChuxuetingoralLiquids;Determination;Gallic

acid

點(diǎn)評：

1、zhixueting應(yīng)為“止血停”而非“出血?！?，自相矛盾。“出血?！币部勺g為

hemorrhage-stopping，以方便國外讀者理解。

2、school可作“（大學(xué)里的）院”解，原意是“藥學(xué)院”，而非“藥理教研室”

，故改之。

3、斜體n表示“正”。

2、原文：

ContentDeterminationofEmodininQingreMingmuCapsules

LUOMing-zhu1,ZHANGHong2(1.HubeiProviceInstituteofDrugControl,

Wuhan430030,China;2.The75310MedicalTeamoftheArmy)

ABSTRACTObjectives:TodeterminationcontentofEmodininQingreMingm

uCapsules.Methods:Tlcswasused,silicagelTlcplate,developingso

lventwasBenzene-Ethylfermate-formicacid-Methanol-water(3:1:0.05:0.1

:0.5)ofwhichtheuppersolutionλS=435nm,λR=530nm.Result:Thelinea

rrelationshipofsampleapplicationwhichrangedbetween0.168-3.09μg

wasgood.Theregressionequationwasbelow:Y=105417.7X-1115.6,r=0.9

995;areragerecoverywas100.53%,RSD=3.38%.Conclusion:Thismethodi

ssimple,accurateandconvenient.

KEYWORDSTLcs;QingremingmuCcapsules;Emodin

修正：

DeterminationofEmodinContentinQingremingmu1Capsules

LUOMing-zhu1,ZHANGHong2(1.HubeiProvicialInstituteofDrugControl

,Wuhan430030,China;2.The75310MedicalTeamoftheArmy)

ABSTRACTObjective:Tosetupamethodforthedetermination（content刪

去）ofEmodincontentinQingreMingmuCapsules.Methods:IntheTLCa

ssay,a0.5%canboxymethylcellulosesodium(wasused刪去)silicagelG

plateandadevelopingsolventwithamixtureofbenzene—ethylformat

e—formicacid—methanol—water(3:1:0.05:0.1:0.5)astheuppersolution

wereused.λS=435nm,λR=530nm.Results:Agoodlinearrelationshipwas

foundwhenthesampleamount(which刪去)rangedbetween0.168-3.09μg

（wasgood刪去）.Theregressionequationwasasfollows:Y=105417.7X-1

115.6,r=0.9995.Theaveragerateofrecoverywas100.53%,RSD=3.38%.Co

nclusion:Themethodissimple,convenientandaccurate.

KEYWORDSTLC;QingreMingmuCcapsules;Emodin

點(diǎn)評：

1、中成藥名用斜體書寫，也可譯作removingpathogenicheattoimproveacui

tyofvision。

3、原文：

ResearchonTheAcuteToxicityofHuningCapsule

XINZhi-wei,ZANGZhi-he,MAIXiao-xia,FENGJun,YANGWan-qing,LIAOH

ong-li(TeachingandResearchSectionofPharmacy,TheThirdMedicalUn

iversity,ChengduCollegeofPLA610081,China)

ABSTRACTObjective:ToobserveandtesttheacutetoxicityofHuningCa

psuleonKunmingmiceafterani.g.Methods:Countthedeathcasesofm

icein7daysafterthei.g.andworkouttheLD50ofHuningCapsule.R

esults:TheLD50ofHuningCapsuleonmiceis3981mg/kg.

KEYWORDSHuningCapsule;AcuteToxicity;LD50

修正：

AnExperimentalStudyoftheAcuteToxicityofHuningCapsules1

XINZhi-wei,ZANGZhi-he,MAIXiao-xia,FENGJun,YANGWan-qing,LIAOH

ong-li(TeachingandResearchSectionofPharmacy,ChengduMilitaryMed

icalCollege,TheThirdMilitaryMedicalUniversity,Chengdu610081,Ch

ina)

ABSTRACTObjective:ToobserveanddeterminetheacutetoxicityofHuni

ngcapsules(onKunmingmice刪去)afterasingleintragastricadministr

ationinthemouse.Methods:50Kunmingmicewererandomlydividedinto

5equalgroups,with10animalsineachgroup.Asingledoseof7500,

5630,4200,3150and2360mg/kg-1ofthecontentofthecapsulesweread

ministenedthroughagastrictubetoeachofthemiceofthe5groups,

respectively.Thenumbersofthedeathsofthemicewithin7dayswere

noteddownandthemediarletherdose(LD50)ofHuningCapsuleswascal

culated.(Countthedeathcasesofmicein7daysafterthei.g.andwo

rkouttheLD50ofHuningCapsule.刪去)Results:TheLD50ofHuningCa

psuleinmicewas3981mg/kg.Conclusion:HuningCapsuleshaveonlyami

noracutetoxicity.Itisthereforesafetousethedrugclinically.Fu

rtherstudyofitstoxicityinlong-termapplicationisrequired.

KEYWORDSHuningCapsules;Toxicity,acute;LD50

點(diǎn)評：

1、“呼寧膠囊”也可譯作antitussiveandantiasthmaticcapsules.